You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

Details for Patent: 11,266,622


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,266,622
Title:Method of treatment
Abstract: Embodiments of the invention relate to the treatment of sleep disturbances in individuals with Smith-Magenis Syndrome (SMS).
Inventor(s): Lavedan; Christian (Potomac, MD), Polymeropoulos; Mihael H. (Potomac, MD)
Assignee: VANDA PHARMACEUTICALS INC. (Washington, DC)
Application Number:16/848,150
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using the Example of United States Patent 11,266,622

Introduction

When analyzing the scope and claims of a U.S. patent, it is crucial to understand the various tools and resources available, as well as the methodologies involved. This article will provide a comprehensive guide on how to conduct such an analysis, using United States Patent 11,266,622 as an example.

Understanding the Basics of U.S. Patents

Before diving into the specifics of a patent, it's essential to understand the role of the U.S. Patent and Trademark Office (USPTO) and the types of patents that can be granted. The USPTO is responsible for granting U.S. patents and registering trademarks, and it offers various resources for searching and analyzing patents[2].

Tools for Patent Search and Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching existing patents and published patent applications. This tool replaced legacy search tools like PubEast, PubWest, PatFT, and AppFT, offering enhanced access to prior art[1].

Global Dossier

The Global Dossier provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices. This service helps in identifying the patent family for a specific application and accessing dossier, classification, and citation data[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for detailed analysis[1].

Steps to Analyze a U.S. Patent

Step 1: Locate the Patent

To analyze a specific patent, such as United States Patent 11,266,622, start by locating it through the USPTO's Patent Public Search tool or other search resources.

Step 2: Review the Patent Claims

Patent claims are the most critical part of a patent as they define the scope of the invention. The Patent Claims Research Dataset, provided by the USPTO, contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can help in understanding claim-level statistics and document-level statistics[3].

Step 3: Examine the Patent Description and Drawings

The patent description and drawings provide detailed information about the invention, including its components, functionality, and any variations. These sections help in understanding the context and scope of the claims.

Step 4: Identify Prior Art and Citations

Using tools like the Common Citation Document (CCD), you can access up-to-date citation data relating to the patent applications of the IP5 Offices. This helps in identifying prior art and understanding how the patent fits into the broader patent landscape[1].

Step 5: Analyze Office Actions and File Histories

The Global Dossier and Patent Examination Data System (PEDS) provide access to office actions and file histories, which can reveal the patent's prosecution history and any challenges or amendments made during the application process[1].

Example Analysis: United States Patent 11,266,622

Step 1: Locate the Patent

Using the Patent Public Search tool, locate United States Patent 11,266,622.

Step 2: Review the Patent Claims

  • Independent Claims: Identify the independent claims, which define the broadest scope of the invention.
  • Dependent Claims: Analyze the dependent claims, which narrow down the scope of the invention.
  • Claim Language: Pay attention to the specific language used in the claims, as it can significantly impact the patent's scope.

Step 3: Examine the Patent Description and Drawings

  • Detailed Description: Read through the detailed description to understand the invention's components, functionality, and any variations.
  • Drawings: Study the drawings to visualize the invention and its components.

Step 4: Identify Prior Art and Citations

  • CCD: Use the Common Citation Document to identify prior art cited by all participating offices for the family members of the patent application.
  • Citations: Analyze the citations to understand how the patent builds upon existing knowledge and how it differs from prior art.

Step 5: Analyze Office Actions and File Histories

  • Global Dossier: Access the file histories and office actions through the Global Dossier to understand the patent's prosecution history.
  • PEDS: Use the Patent Examination Data System to download and analyze bibliographic data related to the patent application.

Legal and Practical Considerations

Patent Scope and Claims

The scope of a patent is defined by its claims. A study by the USPTO's Office of Chief Economist highlights the importance of patent scope measurements, which include newly-developed measures to assess the breadth and depth of patent claims[3].

Litigation and Enforcement

Patent litigation can be costly and time-consuming. The potential for litigation and the need to enforce patents are critical considerations when analyzing a patent's scope and claims. For example, companies like Vanda Pharmaceuticals often engage in lawsuits to protect or enforce their patents[4].

Small Claims Patent Court

There is ongoing discussion about the feasibility of a small claims patent court, which could impact how patent disputes are resolved. The Administrative Conference of the United States (ACUS) has conducted studies on this topic, gathering input from a wide range of stakeholders[5].

Key Takeaways

  • Use Advanced Search Tools: Utilize tools like the Patent Public Search, Global Dossier, and CCD to gather comprehensive information about a patent.
  • Analyze Claims Carefully: The claims section is crucial in defining the patent's scope.
  • Understand Prior Art: Identifying prior art helps in understanding the patent's novelty and non-obviousness.
  • Review Prosecution History: Office actions and file histories provide valuable insights into the patent's validity and potential challenges.
  • Consider Legal and Practical Implications: Patent scope, litigation, and enforcement are critical aspects to consider when analyzing a patent.

FAQs

Q: How do I locate a specific U.S. patent?

A: You can locate a specific U.S. patent using the USPTO's Patent Public Search tool or by visiting a Patent and Trademark Resource Center (PTRC).

Q: What is the importance of the claims section in a patent?

A: The claims section defines the scope of the invention and is the most critical part of a patent.

Q: How can I access prior art related to a patent?

A: Use the Common Citation Document (CCD) to access up-to-date citation data relating to the patent applications of the IP5 Offices.

Q: What is the Global Dossier, and how is it useful?

A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping users identify the patent family and access dossier, classification, and citation data.

Q: Why is it important to analyze office actions and file histories?

A: Analyzing office actions and file histories helps in understanding the patent's prosecution history, including any challenges or amendments made during the application process.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Annual Reports - Vanda Pharmaceuticals INC: https://www.annualreports.co.uk/HostedData/AnnualReportArchive/v/NASDAQ_VNDA_2022.pdf
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,266,622

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vanda Pharms Inc HETLIOZ tasimelteon CAPSULE;ORAL 205677-001 Jan 31, 2014 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF NIGHTTIME SLEEP DISTURBANCES IN SMITH-MAGENIS SYNDROME BY ADMINISTERING TASIMELTEON ⤷  Try for Free
Vanda Pharms Inc HETLIOZ LQ tasimelteon SUSPENSION;ORAL 214517-001 Dec 1, 2020 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF NIGHTTIME SLEEP DISTURBANCES IN SMITH-MAGENIS SYNDROME BY ADMINISTERING TASIMELTEON ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,266,622

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015312252 ⤷  Try for Free
Australia 2020239640 ⤷  Try for Free
Brazil 112017003644 ⤷  Try for Free
Canada 2957588 ⤷  Try for Free
Canada 3124872 ⤷  Try for Free
China 106604726 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.